Please assess the completion status of the following clinical trial:

Trial Title: Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* hyperlipidemia~* urinary protein~* diabetes~Exclusion Criteria:~* previous rosuvastatin treatment \< 6 months prior to Visit 1~* statin intolerance~* severe hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Rosuvastatin 10 mg
- 2 (Type: EXPERIMENTAL): Rosuvastatin 40 mg
- 3 (Type: ACTIVE_COMPARATOR): Atorvastatin 80 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).